Bayer sues J&J over prostate cancer drug ads - NJBIZ
The basics: Dispute centers on real-world data showing a 51% lower death risk with Erleada Bayer seeks injunction, corrective statement and monetary damages under the Lanham Act Whippany-based B...
Read more